Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
Reported purchases exceed sales by $3.8MOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
Company profile
BioSig Technologies is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Insider trading | Relationship | Date | Transaction | Cost | Shares | Value | Shares total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Lekstrom Morgan Lee | Interim Executive Chairman | Jun 12 '26 | Buy | $0.99 | 50,000 | $49,750 | 359,500 | Jun 15 01:21 PM |
| Williams Mitchell Young | Chief Investment Officer | Jun 01 '26 | Sale | $1.05 | 23,810 | $24,915 | 3,013,838 | Jun 02 09:54 PM |
| Lekstrom Morgan Lee | Interim Executive Chairman | May 28 '26 | Buy | $1.47 | 34,000 | $49,980 | 309,000 | May 28 02:33 PM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.